Ruminant BioTech is an agricultural technology company focused on reducing livestock methane emissions through a proprietary, slow-release bolus designed for ruminant animals. The product is intended to inhibit methane production in animals such as cattle and sheep, helping farmers meet environmental targets while maintaining productivity. With fresh capital in hand, the company plans to begin commercial rollout of its bolus in New Zealand and Australia early next year. The Series A raise signals investor confidence in both the technology and the growing market demand for climate-friendly livestock solutions. Although the round closed below its original $20 million–$25 million target, the $17 million injection provides sufficient runway for manufacturing scale-up, regulatory approvals, and early market entry. No revenue or customer figures were disclosed, but the company’s focus on commercialization suggests it is transitioning from R&D to revenue generation.

Total raised

$17M

Funding rounds

1

Latest round

Series A

Latest activity

Nov 2025